ArticleJournal of clinical and translational science2026
Navigating the transition from early-stage investigator to mid-career: Challenges and opportunities for developing careers in diabetes translational research.
Article in Journal of clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a significant health burden, and recent reports indicate an increase in diabetes-related complications in the United States (U.S.). The mission of the National Institute of Diabetes and Digestive and Kidney Diseases Centers for Diabetes Translational Research (CDTR) is to improve the translation of research findings in diabetes prevention and treatment by supporting research across the translational science spectrum. To facilitate this mission, it is imperative to support multidisciplinary translational early-stage investigators (ESIs) to address the societal-, environmental-, and individual-level factors that impact diabetes outcomes. In this special communication article, we characterize the challenges, opportunities, and needs of ESIs transitioning to mid-careers whose goals are to develop a career in diabetes translational research. These challenges and opportunities were collected from 34 ESIs and 19 senior faculty members from 23 institutions across the U.S. who attended the inaugural CDTR National Enrichment Program Conference. Our findings aim to promote the engagement of ESIs in diabetes translational research and provide guidance in strengthening and sustaining their research careers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.